Isothiourea derivatives

Details for Australian Patent Application No. 2005219531 (hide)

Owner Novartis AG

Inventors Thoma, Gebhard; Glickman, Fraser; Zerwes, Hans-Gunter; Streiff, Markus

Agent Davies Collison Cave

Pub. Number AU-B-2005219531

PCT Pub. Number WO2005/085219

Priority 0404434.3 27.02.04 GB

Filing date 25 February 2005

Wipo publication date 15 September 2005

Acceptance publication date 15 January 2009

International Classifications

C07D 277/42 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

Event Publications

31 August 2006 PCT application entered the National Phase

  PCT publication WO2005/085219 Priority application(s): WO2005/085219

15 January 2009 Application Accepted

  Published as AU-B-2005219531

14 May 2009 Standard Patent Sealed

23 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005219533-Transgenic expression constructs for vegetative plant tissue specific expres- sion of nucleic acids

2005219529-Method for producing highly condensed solid-phase polyesters